Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants

British Journal of Pharmacology

Volumn 130, Issue 3, 2000, Pages 641-649

  Majima, Masataka ^a   Hayashi, Izumi ^a   Muramatsu, Michiko ^a   Katada, Jun ^a   Yamashina, Shohei ^a   Katori, Makoto ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Antisense oligonuculeotide; COX 2; Prostaglandin; Vascular endothelial growth factor

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANTISENSE OLIGONUCLEOTIDE; BASIC FIBROBLAST GROWTH FACTOR; BERAPROST; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; TILMACOXIB; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRANULOMA; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR VASCULARIZATION;

EID: 0034029780     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703327     Document Type: Article

References (35)

1. ALLISON, A.C. & KOWALSKI, W.J. (1993). Vascular Endothelium. In Receptors and Transduction Mechanisms, ed. Catravas, J.D., Gillis, C.N. & Ryan, U.S. pp. 99-110. New York: Plenum Press.
2. ANDRE, S.P., FAN, T.-P.D. & LEWIS, G.P. (1987). Quantitative method for measuring adjuvant-induced granuloma angiogenesis in insulin-treated diabetic mice. Br. J. Exp. Pathol., 68, 755-766.
3. ANGERMAN-STEWART, J.A., ELING, T.E. & GLASGOW, W.C. (1995). Prostaglandin H synthase-2 is induced in Syrian hamster embryo cells in response to basic fibroblast growth factor. Arch. Biochem. Biophys., 318, 378-386.
4. BANAI, S., JAKLITSCH, M.T., SHOU, M., LAZAROUS, D.F., SCHEINOWITZ, M., BIRO, S., EPSTEIN, S.E. & UNGER, E.F. (1994). Angiogenetic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth in dog. Circulation, 89, 2183-2189.
5. BEN-AV, P., CROFFORD, L.J., WILDER, R.L. & HLA, T. (1995). Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potent mechanism for inflammatory angiogenesis. FEBS Lett., 372, 83-87.
6. COLVILLE-NASH, P.R. & SCOTT, D.L. (1992). Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann. Rheum. Dis., 51, 919-925.
7. CONNOLLY, D.T., HEUVELMAN, D.M., NELSON, R., OLANDER, J.V., EPPLEY, B.L., DELFINO, J.J., SIEGEL, N.R., LEIMGRUBER, R.M. & FEDER, J. (1989). Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest., 84, 1470-1478.
8. CROFFORD, L.J., WIELDER, R.N., RISTIMAKI, A.P., SANO, H., REMMERS, E.F., EPPS, H.R. & HLA, T. (1994). Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. J. Clin. Invest., 93, 1095-1101.
9. DUBOIS, R.N., TSUJII, M., BISHOP, P., AWAD, J.A., MAKITA, K. & LANAHAN, A. (1995). Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am. J. Physiol., 266, G822-G827.
10. FERRARA, N., HOUCK, K., JAKEMAN, L. & LEUNG, D.W. (1992). Molecular and biological properties of the vascular endothelial growth factor family of proteins. Enderinol. Rev., 13, 18-70.
11. FOLKMAN, J. (1971). Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285, 1182-1186.
12. 2 and angiogenesis. Prog. Soc. Exp. Biol. Med., 172, 214-218.
13. HAMASAKI, Y. & ELING, T.E. (1995). EGF and TPA stimulate de novo synthasis of PGHS-1 and PGSH-2 through different signal transduction pathways. Prostaglandins Leukot. Essent. Fatty Acids, 53, 225-229.
14. HARADA, S., NAGY, J.A., SULLIVAN, K.A., THOMAS, K.A., ENDO, N., RODAN, G.A. & RODAN, S.B. (1994). Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblast. J. Clin. Invest., 93, 2490-2496.
15. HARTNER, A., GOPPELT-STRUEBE, M. & HILGERS, K.F. (1998). Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension. Hypertension, 31, 201-205.
16. HERSCHMAN, H.R. (1994). Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev., 13, 241-256.
17. HLA, T. & NEILSON, K. (1992). Human cyclooxygenase-2 cDNA. Prof. Natl. Acad. Sci. USA, 89, 7384-7388.
18. KAWAGUCHI, H., PILBEAM, C.C., ABREU, G., FLETCHER, B.S., HERSCHMAN, R.H., RAISZ, R.L. & HURLEY, M.M. (1995). Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. J. Clin. Invest., 96, 923-930.
19. KUJUBU, D.A., REDDY, S.T., FLETCHER, B.S. & HERSCHMAN, H.R. (1993). Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen stimulated Swiss 3T3 cells. J. Biol. Chem., 268, 5425-5430.
20. MAJIMA, M., ISONO, M., IKEDA, Y., HAYASHI, I., HATANAKA, K., HARADA, Y., KATSUMATA, O., YAMASHINA, S., KATORI, M. & YAMAMOTO, S. (1997). Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants. Jpn. J. Pharmacol., 75, 105-114.
21. MASFERRER, J.L., ZWEIFEL, B.S., MANNING, P.T., HAUSER, S.D., LEAHY, K.M., SMITH, W.G., ISAKSON, P.C. & SEIBERT, K. (1994). Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. U.S.A., 91, 3228-3232.
22. MICHAELSON, I.C. (1948). The mode of development the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol., U.K., 68, 137 180.
23. MIZUNO, H., SAKAMOTO, C., MATSUDA, K., WADA, K., UCHIDA, T., NOGUCHI, H., AKAMATSU, T. & KASUGA, M. (1997). Induction of cyclooxygenase-2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology, 112, 387-397.
24. NARKO, K., RISTIMAKI, A., MACPHEE, M., SMITH, E., HAUDENSCHILD, C.C. & HLA, T. (1997). Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-over-expression. J. Biol. Chem., 272, 21455-21460.
25. O'BANION, M.K., WINN, V.D. & YOUNG, D.A. (1992). cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory COX. Proc. Natl. Acad. Sci. U.S.A., 89, 4888-4892.
26. PEACOCK, D.J., BANQUERIGO, M.L. & BRAHN, E. (1992). Angiogenesis inhibition suppresses collagen arthritis. J. Exp. Med., 175, 1135-1138.
27. SANO, H., HLA, T., MAIER, J.A.M., CROFFORD, L.J., CASE, J.P., MACIAG, T. & WILDER, R.L. (1992). In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J. Clin. Invest., 89, 97-108.
28. SEIBERT, K., ZHANG, Y., LEAHY, K., HAUSER, S., MASFERRER, J., PERKINS, W., LEE, L. & ISAKSON, P. (1994). Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. U.S.A., 91, 12013 12017.
29. SENGER, D.R., CONNOLY, D.T., WATER, L., FEDER, J. & DVORAK, H.F. (1990). Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer. Res., 50, 1774-1778.
30. SHOUDA, T., HATANAKA, K., SAITO, M., MAJIMA, M., OGINO, M., HARADA, Y., NISHIJIMA, M., KATORI, M. & YAMAMOTO, S. (1995). Induction of cyclooxygenase Type-2 (COX-2) in rat endometrium at the peak of serum estradiol during the estrous cycle. Jpn. J. Pharmacol., 69, 289-291.
31. 2 generation after administration of mild hyperosmotic saline solution into gastric lumen. Eicosanoids, 3, 23-27.
32. TUJII, M., KAWANO, S., TSUJI, S., SAWAOKA, H., HORI, H. & DUBOIS, R.N. (1998). Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell., 93, 705-716.
33. WALLANCE, J.L. (1999). Selective COX-2 inhibitors: is the water becoming muddy?. Tips., 20, 4-6.
34. WISE, G.N. (1956). Retinal neovascularization. Trans. Am. Ophthalmol. Soc., 54, 729-826.
35. 1 and copper in angiogenesis. J. Natl. Cancer. Inst., 69, 475-482.